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A lthough heart disease is the principal cause of death in many countries and 
its diagnosis is of major importance, meth- 
ods for direlct visualization of the myocar- 
dium in intact subjects are few. The 
roentgenogram of the heart shows the 
myocardium plus other tissues, especially 
the blood contained in the cardiac cavities, 
as a single shadow. Various techniques show 
cavities and vessels rather than the myo- 
cardium itself. On the basis of the im- 
portant earlier studies which had demon- 
strated mycvardial uptake of potassium 
and its analogues,’ it was possible to develop 
a method for myocardial scintigrams,‘J 
using salts of cesium-131. This method per- 
mitted the demonstration of the left ven- 
tricular myocardium through the intact 
chest wall, without significant contribution 
to the image from the cardiac blood pool 
or adjacent non-cardiac tissues. After origi- 
nal developrnent of the technique in dogs, 
it was extended to humans and the myo- 
cardial scintigram has subsequently been 
shown capable of demonstrating myocar- 
dial infarcts,2-g aneurysm of the left ven- 
tricle,2j6 cardiomyopathies,7,8 neoplasm in 
the ventricular wall,‘O and rejection of the 
transplanted heart.” 
However, the long biologic half-life of 
cesium creates difficulties, not only from 
the standpoint of radiation dose, but also 
through interference with performance of 
serial scintigrams. As skeletal muscles re- 
tain cesium much longer than cardiac 
muscle,12,13 the uptake by intercostal mus- 
cles interferes with serial myocardial scinti- 
grams during the days that follow injection 
of a single dose of cesium-131. Moreover, 
its principal emission, a 29.4 KEV x-ray, 
poses a considerable problem as a result of 
its low energy and consequent high absorp- 
tion in tissues. Therefore, although cesium- 
131 has proved an important radionuclide 
by permitting the demonstration of the 
validity of the myocardial scintigram for 
diagnosis, the general clinical usefulness of 
the myocardial scintigram would be greatly 
increased by the availability of a more 
convenient radioactive compound for this 
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purpose. Toluidine l)lue (tolonium clllo- 
ride), C1~HI&:SCI, a phennzatllioniun~ 
dye, \vas found to concentrate selecti\.el> 
in parathyroid glands of dogs and man after 
intravenous or intra-arterial injection.‘” 
Toluidine blue has subsequently been found 
to concentrate heavily in myocardium of 
dogs after intravenous injection.‘j Iodoto- 
luidine blue, labeled with iodine-131 or 
iodine-125, was suggested as a potential 
radioactive imaging agent for parathyroid 
scintigrams on the basis of such distribution 
studies.16 Moreover, a preliminary study’7 
showed that unlabeled toluidine blue (here- 
after abbreviated TB) \vas present in de- 
creased concentration in myocardial in- 
farcts, as compared to normal myocardium, 
after intravenous injection in dogs. As the 
possibility of obtaining myocardial scinti- 
grams with a compound of iodine-131 sug- 
gested a I\-ay of avoiding the problem posed 
by the \veak emission of cesium-131, further 
in\-estigation of radioacti1.e iodotoluidine 
blue (hereafter abbreviated as ITB) as a 
myocardial imaging agent seemed indi- 
cated. 
But initial studies \vith ITB bvere re- 
ported as discouraging 1)~ other authors, as 
they did not confirm a significant selective 
uptake of ITB by parathyroid glands1a-20 or 
myocardium18,20 of rats after intra\.enous 
injection of the radioactive compound. It 
is of interest that the use of a pre- 
liminary priming or “loading” dose of the 
stable compound, TB, before injection 
of the radioactive compound, ITB, I\-as 
not reported in any of these negati1.e 
studies. 
We have no\v demonstrated, in l)oth rats 
and dogs, a significant selecti\-e uptake of 
ITB by myocardium \\hen the administra- 
tion of this radioactive compound is first 
preceded by a priming dose of the staljle 
compound TB. This uptake by normal 
myocardium permits demonstration of 
myocardial infarcts as “cold” areas of 
decreased uptake in dogs. We have further 
demonstrated that the major fraction of 
administered radioactive iodine given as 
ITB is excreted n-ith sufficient rapidity to 
give this compound significant advantage 
over radioactive cesium as a myocardial 
imaging agent if serial scintigrams are 
desired. 
Methods 
Toluidine blue (TB) I:SI’, \vas dissolved 
in isotonic saline solution in appropriate 
concentrations to pro\-ide the required dose 
xvhen given at a rate of 0.02 ml. per minute 
to rats and 1 ml. per minute to dogs. Iodi- 
nated toluidine blue (ITB), labeled \vith 
either iodine-131 or iodine-125, \\-a~ ob- 
tained* in specific activities ranging from 
0.3 to 1.2 millicuries per milligram. The 
dose of ITB, given as a bolus intravenously, 
was 60 microcuries per kilogram of body 
weight and 20 microcuries per kilogram of 
body weight for rats and dogs, respectively. 
Rats used in this study weighed from 153 to 
410 grams. Dogs weighed from 8 to 17 
kilograms. 
Studies of the efect of priming doses of 
stable TR on subsequent distribution of radio- 
active ITB. 
RATS. Forty-nine rats were divided into 
7 groups of 7 each and were anesthetized 
\vith chloral hydrate. To establish the effect 
of TB, doses ranging from 0 to 10 mg. per 
kilogram of body weight were administered 
in isotonic saline through a tail vein at a 
rate of 0.02 ml. per minute over various 
time periods. One group of rats served as 
controls, receiving no TB; this control 
group received isotonic saline alone prior 
to the administration of ITB. Immediately 
following the completion of the infusion of 
the priming dose, all rats were given ITB. 
The rats were killed 15 minutes after ad- 
ministration of ITB. Tissue samples from 
all major thoracic and abdominal organs, 
including 4 samples of left ventricular myo- 
cardium, lvere taken from each rat. The 
samples lvere jveighed and counted in a 
scintillation detector. 
IKXS. Eight dogs \vere di\.idecl into 4 
groups of 2 each. I’riming doses of TB 
ranging from 1 mg. per kilogram of body 
\veight to 10 mg. per kilogram of body 
I\-eight were given intravenously at an 
infusion rate of 1 ml. per minute over a 
period of 45 minutes. Following completion 
of the infusion of TB, ITB was given intra- 
venously to all dogs. The dogs lvere killed 
15 minutes after administration of ITB. 
Tissue samples \vere taken from all the 
*We are grateful to Gerald Bruno of E. R. Squibb and Sons. 
who generously supplied the radioiodinated toluidine blue. 
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major thoracic and abdominal organs, in- 
cluding six samples of left ventricular myo- 
cardium from each dog. The samples were 
weighed and counted in a scintillation 
detector. 
Studies utilizing a Jixed priming dose of 
stable TB. Flollowing the experiments de- 
scribed above, a standard priming dose of 
10 mg. per ki.logram of body weight, given 
intravenously over a period of 45 minutes, 
was selected. Except as otherwise specified, 
all studies described below utilized this 
priming dose for both rats and dogs. The 
bolus dose of ITB was given immediately 
after the conclusion of the infusion of TB. 
Retention qf radioactivity by myocardium 
and whole bod;y of dogs after injection of ITB. 
Eight dogs were divided into four groups 
of two each. Each dog received a priming 
dose of TB amd a subsequent injection of 
ITB, as described above. These dogs were 
killed at periods ranging from 15 to 90 
minutes after administration of ITB. 
Tissue samples, including six samples from 
left ventricular myocardium, were removed 
from each clog and were weighed and 
counted in a scintillation detector. 
For an estimation of whole body biologic 
half-life of radioactive iodine when given as 
ITB, three additional dogs were given TB 
and ITB. The dogs were housed in meta- 
bolic cages; excreta were collected and 
counted daily. The dogs were killed from 7 
to 11 days later. A complete set of over 30 
tissues was removed from each dog. Appro- 
priate samples were weighed and counted 
in a scintillation detector. Wherever possi- 
ble, whole organs were weighed; otherwise, 
the weight of whole organs was estimated 
from a standard reference table.21 
Two other dogs received TB and ITB. 
They were studied serially by whole body 
scintigrams, using an Ohio Nuclear Scanner 
with j-inch crystal, 85-hole collimator, and 
scan minification recording attachment, 
permitting automatic reduction of the 
scintigram to one-fifth original size. The 
serial whole body scintigrams were obtained 
at various times ranging from one-half hour 
to 5 days after injection of ITB. 
Myocardial scintigrams. Eleven normal 
dogs received TB and ITB. Approximately 
15 minutes after injection of ITB, the dogs 
were scanned under pentobarbital anes- 
thesia in the supine position with the legs 
extended. In some instances they were sub- 
sequently scanned in the left lateral posi- 
tion also. For these scintigrams a Baird- 
Atomic Scanner with 3-inch crystal and 
19-hole focusing collimator was used. The 
scanning speed ranged from 7.5 to 10 inches 
per minute with the scanner set for sharp 
contrast (“per cent background” setting at 
80). Further details of the techniques em- 
ployed have been previously described.2 
Experimental myocardial infarcts were 
induced in 11 dogs by ligation of the ante- 
rior descending branch of the left coronary 
artery under sodium thiamylal anesthesia. 
(Except in the two instances noted below, 
none of these dogs had previously been 
studied among the 11 normals described 
in the previous paragraph.) After ligation 
of the coronary artery, the chest wall in- 
cision was closed and each animal was al- 
lowed to recover. Twenty-four hours after 
coronary artery ligation each dog was again 
anesthetized, using pentobarbital. Each 
dog received 10 mg. per kilogram of body 
weight of TB over a period of 45 minutes 
followed by 20 microcuries per kilogram of 
body weight of ITB intravenously as a 
single bolus dose. Fifteen minutes after the 
administration of the radioactive com- 
pound each dog was killed by an excessive 
intravenous dose of barbiturate. \Iyocar- 
dial scintigrams were then performed, using 
the same scanning factors employed for the 
normal dogs that had been scanned alive. 
After completion of the scintigrams, the 
heart was removed from each killed dog, 
emptied of all blood, and scanned again as 
an isolated organ. Samples of auricles, right 
ventricle, lung, liver, rib, muscle, skin, and 
fat were taken for scintillation counting. 
Three samples of myocardium from areas 
of anterior left ventricle distal to the site of 
arterial ligation and three control samples 
(one from a site proximal to ligation and 
two from posterior left ventricle areas not 
dependent upon the ligated artery for their 
blood supply) lvere also taken; these were 
each divided to permit histologic exami- 
nation as well as scintillation counting. 
Further details of the techniques employed 
have been previously described.22 Three of 
the 11 normal dogs described above were 
subjected to coronary artery ligation 4 days 
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Table I. Kadioactivify in tissws of rats given various priming doses qfsfablp toluidine b/lie before 
radio-iodinated toluidine blue* 
((‘iI administered doset) 
Radioactivity -. --~~~-~ 1n 
Priming dose (mg./kg.) atld Gm. tissue 
duration of infusion ~------------~~~-_-~-~_--~~-~---- __._._. .___~_ 
I 




Saline control 0.34: 0.81 0.14 
5 in 15 minutes 0.49 0.43 0 10 
5 in 30 minutes 0.32 0.45 0.09 
5 in 90 minutes 0.59 0.44 0.08 
10 in 4.5 minutes 1.205 0.62 0.10 
10 in 90 minutes 0 82s 0.365 0.065 
10 in 180 minutes 0.78 0.328 0.07s 
*See text for further details. 
tin this and subsequent tables the administered dose used in the calculation is the number of microcuries given per kilogram of body 
weight. 
iEach value represents the mean of 7 rats. 
$Differs significantly (p < 0.05) from control. 
after a normal myocardial scintigram had 
been obtained in the living dogs. Two of 
these 3 were among the 11 dogs that re- 
ceived a dose of TB and ITB 24 hours after 
ligation and underwent myocardial scan- 
ning after killing. The purpose of sacrificing 
dogs with myocardial infarcts before scan- 
ning was to insure that the subsequent 
scintillation counting of tissue samples 
would permit comparable data to be ob- 
tained among 11 dogs that had all lived 
15 minutes after injection of the radio- 
nuclide. However, one normal dog that 
subsequently underwent coronary artery 
ligation and received TB and ITB 24 hours 
later was not killed. This permitted a scinti- 
gram of the infarct to be obtained in a 
living dog. Although tissue data from this 
dog could not, therefore, be compared \vith 
data obtained from the 11 dogs killed 15 
minutes after ITB injection, this additional 
dog was killed at the conclusion of the 
myocardial scanning in order to permit 
histologic confirmation of infarction. 
Results 
Studies of the effect of priming doses of 
stable TB on subsequent distribution of radio- 
active ITB. 
KITS. Table I compares the distribution 
of ITB in rats given various priming doses 
of TB over various periods of time before 
injection of ITB. Analysis of variance was 
first performed on all uptakes of ITB by left 
ventricle, to determine whether any sig- 
nificant difference existed among the 7 
means-i.e., to determine whether the use 
of any priming dose significantly increased 
uptake over control. After this analysis ha3 
demonstrated a significant (p < 0.05) dif- 
ference, further analysis was carried out bq 
Duncan’s multiple range test to determine 
which of the means differed significantly 
from the control. The latter test demon- 
strated a significantly higher (p < 0.05) up- 
take of radioactive iodine by left ventricle 
in rats given 10 mg. per kilogram of body 
weight of TB over a 45 minute period, when 
compared to controls. The respective up- 
takes were 1.20 * 0.66 per cent adminis- 
tered dose per gram of tissue and 0.34 * 
0.13 per cent administered dose per gram. 
Similarly, the uptake by left ventricle in 
rats receiving 10 mg. per kilogram of body 
weight TB over 90 minutes (0.82 * 0.38 
per cent administered dose per gram) was 
significantly (p < 0.05) higher than uptake 
by controls. Uptake by left ventricle of rats 
receiving 10 mg. per kilogram of body 
weight over 180 minutes, and uptake by left 
ventricle of rats receiving priming doses 
of 5 mg. per kilogram of body weight, did 
not differ significantly from controls. 
Similar statistical analysis, using the 
multiple range test, showed that the uptake 
of radioactive iodine by liver was signifi- 
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Table II. Radioactivity in tissues of dogs given various priming doses of stable toluidine blue 
before radio-iodinated toluidine blue* 
Radioactivity 
y. administered dose 
in Ratio of Tadioactivity 
Priming dost ( 
Gm. tissue 
> 
(W./k.) _ -___-- ___- 
LV LV 
Left ventricle Blood Liver -- - 
(L VI (B) CL) B L 
1 0.7st 0.11 1.28 7.1 0.6 
3 1.35 0.10 1.16 13.5 1.2 
5 1.61 0.10 1.49 16.1 1.1 
10 1.56 0.12 0.98 13.0 1.6 
*See text for further- details. 
tEach value mxesents the mean of 2 dons. 
cantly (p < 0.05) less in rats receiving a 
priming dose of TB, 10 mg. per kilogram of 
body weight over 90 minutes, or 10 mg. per 
kilogram of body weight over 180 minutes, 
as compared to controls. No other treat- 
ment resulted in a significant difference 
from control values for hepatic uptake. 
The radioactivity of blood followed the 
pattern seen in liver, with significant 
(p < 0.05) decreases in rats receiving prim- 
ing doses of 10 mg. per kilogram of body 
weight over 90 minutes, or 10 mg. per kilo- 
gram of body weight over 180 minutes, as 
compared to controls. 
Except for liver, uptake by non-cardiac 
tissues adjacent to the heart was not suf- 
ficiently high in rats given priming doses of 
TB to lead to significant interference with 
the use of ITB as a myocardial imaging 
agent (see below). 
DOGS. As with rats, the most important 
uptake by an organ adjacent to the heart, 
likely to cause interference with the myo- 
cardial scintigram, was uptake by liver. 
Table II shows the radioactivity in left 
ventricle, liver, and blood of dogs receiving 
various priming doses of stable TB. The 
use of a priming dose increases the ratios, 
radioactivity in left ventricle/radioactivity 
in blood, and radioactivity in left ventricle/ 
radioactivity in liver, thus increasing the 
likelihood of good resolution of the left 
ventricle by scanning techniques. In dogs 
this effect of a priming dose is chiefly by 
way of increased uptake by left ventricle. 
Studies utilizing a jixed priming dose of 
stable TB. 
RETENTION OF RADIOACTIVITY BY MYO- 
CARDIUM AND WHOLE BODY OF DOGS AFTER 
INJECTION OF ITB. The concentration of 
radioactivity in left ventricle of dogs at 
various times after injection of ITB is 
shown in Fig. 1. The high uptake of radio- 
activity obtained when a priming dose of 
TB is followed by ITB does not lead to 
prolonged retention of radioactivity in the 
myocardium. 
From the eight actual measurements ob- 
tained during the first 90 minutes after 
injection, the equation shown in Fig. 1 was 
derived.* The curve of this equation is also 
shown in the illustration. The uptake at 24 
hours after injection, calculated from this 
equation, is shown by the dot at the ex- 
treme right of Fig. 1. A ninth dog was 
actually studied at 24 hours and the uptake 
found in this dog is shown by a bar at the 
extreme right. The calculated and deter- 
mined points agree very well. Despite the 
rapid decay of myocardial radioactivity 
during the first 90 minutes after injection, 
the ratio of myocardial radioactivity to 
radioactivity in the blood (not shown in 
Fig. 1) remained >4 at all times during the 
*We acknowledge with thanks the assistance of Dr. John G. 
Wagner. 
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Fig. 1. Concentration of radioactix-e iodine in the 
left \-entricle of dogs at x-nrious times after intra- 
venous injection of ITB. Horizontal lines (-) indi- 
cate measured \-alues. The dot at 1-1 hours represents 
a calculated value. See test for details. 
first 90 minutes. The average of this ratio 
for the eight points during that time was 
10.9. 
The retention of radioactivity in dogs, as 
calculated from daily urine and stool collec- 
tions, is shown in Fig. 2. At the time of 
death, the total radioactivity remaining in 
the carcass of dog A (killed at 7 days), 
dog B (killed at 10 days), and dog C (killed 
at 11 days) was 3.28, 6.15, and 3.84 per 
cent of administered dose, respectively. By 
the usual curve-stripping method, the 
retention curve of radioactivity was separa- 
ble into two components, as shown in 
Fig. 2. The first component had a half-life 
of 0.6, 0.6, and 0.7 days, respectively, in the 
3 dogs (mean, 0.63 days). The second com- 
ponent had a half-life of 24, 32, and 28 
days, respectively, in the 3 dogs (mean, 28 
days). Extrapolation of the second compo- 
nent back to the origin indicated that 24 
per cent, 31 per cent, and 20 per cent of the 
total dose was retained in the 3 dogs, 
respectively, with a mean biologic half-life 
of 28 days. In estimating whole body radi- 
ation dose, we have made the conservative 
assumption that the residual in the carcass 
would not have been excreted and would 
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Fig. 2. Whole-body retention of radioactivity by 
dogs given ITB. 
As it was possible to account for a mean 
of 84 per cent of the administered dose of 
radioactive iodine through the total col- 
lected in urine and stools and the analysis 
of residual radioactk-ity in the carcass, 




Fig. 3. \\‘hole-body scintigrams of Dog No. 1 pi\-en ITB. Thirty minutes after injection of the radioactive 
compound, scanning started at the head and proceeded caudally. The results are shown on the left. The scinti- 
gram on the righ!t shows the same dog, scanned 5 days later. 
calculation of whole body radiation dose, 
using the formulas of Quimby and col- 
leagues23 requires an assumption regarding 
the fate of the 16 per cent which was not 
found in collected urine, stools, and residual 
carcass. In the “best possible case,” one 
assumes that this radioactivity was lost 
very early after administration of the ITB, 
when small errors in collection of the highly 
radioactive excreta would result in signifi- 
cant losses. In the “worst possible case” 
one assumes that the entire 16 per cent was 
actually in th!e carcass, in addition to the 
approximately 4 per cent found by analysis. 
Thus, in the “best possible case” a mean of 
71 per cent of total radioactivity \\-as ex- 
creted as a short half-life component, with 
a biologic half-life of 0.63 days, 25 per cent 
was excreted with a biologic half-life of 28 
days, and 4 per cent remained to be elimi- 
nated by physical decay. The respective 
figures for the “worst possible case” are 
55 per cent, 2.5 per cent, and 20 per cent. 
These data in dogs are useful for esti- 
mating expected radiation dose in man fol- 
lowing the use of ITB. Although species 
differences obviously may exist and cannot 
be resolved until studies are conducted in 
man, this preliminary estimation may be of 
interest. The whole-body combined beta 
and gamma radiation dose, for a 70 kilo- 
gram man receiving 1 microcurie per kilo- 
gram of body weight of ITB, labeled with 
iodine-131, after an appropriate priming 
dose of stable TB, is estimated, on the basis 
of the above assumptions, as 53 millirads 
in the “best possible case” and 73 millirads 
in the “worst possible case.” 
Serial whole-body scintigrams of a dog 
given 10 mg. per kilogram of body weight 
of TB followed by ITB are shown in Fig. 3. 
The scintigrams suggest disappearance of 
most of the radioactivity from the body 
within a few days. The results obtained in 
a second dog subjected to serial scintigrams 
\vere very similar. 
Myocardial scintigrams. Figs. 4 and 5 
show anterior views of normal and infarcted 
myocardium, respectively. Although our 
tissue studies have repeatedly shown that 
uptake by normal right ventricle and atria 
is comparable to uptake by normal left 
ventricle, the myocardial scintigram results 
almost exclusively from radiation ema- 
nating from the left ventricle, as a conse- 
quence of the preponderant mass of the 
latter. Figs. 6 and 7 show lateral views of 
normal and infarcted left ventricle, respec- 
tively. These four scintigrams were ob- 
tained in 4 different dogs. Fig. 8, however, 
63s Carr ct al. 
Fig. 4. Myocardial scinti~r,Im of .L normal doi: he,lrt (I )op No. 1). .\nterior \.iew. For this and all subsequent 
figures a priminp dose 01 -t,rble TR w;t+ ~i\en intr.r\.enotlsll- over a 45 minute Ijeriod, followed by a bolus 
injection of radioactive TTB: xintigr,lm- be<.ln 15 minutes ,lfter the latter injection. Except where otherwise 
specified, the dose of TR \\-a> ;rlway~ 10 m<. per kilou-am of body lveight and each dog was killed at the begin- 
ning of the scintigram. 
Fig. 5. Scintigram of Ijog. No. 3, showing a In)-orardial infarct. Anterior view. Infarcts shown in this and all 
subsequent iiyures were confirmed by hi\tolo<ic examination. 
sho\vs anterior scintigrams ol>tained in the infarction. LMtllough the ratio, concentra- 
same dog before and one day after experi- tion of radioa&\-ity in normal left ven- 
mental myocardial infarction. Fig. 9 shout tricle,!‘concentration of radioactivity in 
lateral scintigrams obtained in still another xvhole blood, varies among individual dogs 
dog, before and one day after experimental and varies to some degree with time after 
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Fig ;. 6. Scintigram of a normal dog heart (Dog No. 4). Lateral view. The priming dose 
kilt ,gram of body weight in this dog. 
of TB was 5 mg. per 
Fig. 7. Scintigram of Dog No. 5, showing a myocardial infarct. Lateral view. 
injection of ITB, the mean ratio at time of in the heart cavities. This was repeatedly 
death in these studies was approximately confirmed by scintigrams of the isolated 
12 to 1. The scintigram after administration hearts, removed from the dog and emptied 
of ITB in these experiments represents of all blood. The emptied hearts gave 
primarily radioactivity from the myo- scintigrams essentially the same as hearts 
cardium, with little contribution from the which contained blood in their cavities, 
low level of activity contained in the blood showing normal left ventricle in the normal 
640 C’czrr cf (11. 
Fig. 8. M)-ocardial scintip-,trw oi I)ox So. 6 before ;~nd after myoc.lrdial infarction. :Jnterjor \.iea-. The scan 
on the left was obtained one day before inf.lrction. The SGU~ on the right W;IS obtained 4 days after infarction. 
Both scintigrams were performed in the li\.ing dog. 
Fig. 9. Myocardial scintigrams of Ilog Ko. 7 before and after myocardial infarction, Lateral x-iew. This dog was 
studied in the same manner as the dog shown in Fig. 8. This dog was alive during the performance of the scan 
on the left and was killed just before performance of the scan on the right. 
dogs and “cold” areas of decreased uptake 
in dogs with myocardial infarcts (Fig. 10). 
Table I I I summarizes the data obtained 
in 11 dogs with myocardial infarctions. 
Actual necrosis of tissue \vas l~istologically 
confirmed in every instance. The mean ra- 
tio, concentration of ITB in infarc.ts/‘con- 
centration in normal left ventricle, \ITas 0.18 
* 0.31. The difference in uptake hy normal 
and infarcted tissue was significant (p < 
0.005) by the “t” test. 
Discussion 
Both iodine-131 and iodine-125 \vere 
used as labels in these experiments in ani- 
mals. The availability of both labels for 
ITB offers in itself the possibility of serial 
scintigrams within a short inter\-al of time, 
as one may easily detect iodine-131 while 
discriminating against iodine-12.5. The use- 
fulness of both of these isotopes in labora- 
tory animals should not obscure the fact 
that iodine-131, \vith its more penetrating 
emission, is likely to be the better isotope in 
man. The emission of iodine-125 \vould not 
represent a significant advantage over that 
of cesium-131, while iodine-131 has a sig- 
nificant advantage in this respect. The 
rapid disappearance of radioactivity 
through excretion is an additional ad- 
vantage, permitting serial scintigrams with- 
out excessive radiation dose. The rapid 
disappearance of radioactivity from the 
myocardium strongly suggests that serial 
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Fig. 10. Myocardial scintigrams of isolated hearts. Left: normal heart. Right: heart showing myocardial infarct 
at the apex. A normal dog and a dog with a myocardial infarct, respectively, each received TB and ITB. The 
respective TB doses were 1 mg. per kilogram of body weight and 10 mg. per kilogram of body weight. Fifteen 
minutes after injection of ITB the dogs were killed and their hearts were removed. After all blood had been 
emptied from the heart cavities, as previously described, n the hearts were scanned. The actual outlines of the 
heart are projected on the scan. The density represents left ventricular muscle. 
xintigrams may be obtained by repeated 
doses of ITB, even if labeled with iodine- 
131. 
Although the rapid disappearance of 
radioactivity from the myocardium after 
administration of ITB requires that scinti- 
grams be performed promptly after admin- 
istration of ITB, this has not caused signifi- 
cant problems. The radioactivity of the 
normal left ventricle remains much higher 
than the radioactivity of infarcted areas or 
of blood, even several hours after adminis- 
tration of ITB-i.e., there is a comparable 
decline of radioactivity in all three types of 
tissue. Thereflore, the ratio of radioactivity 
in target tissue to that in non-target tissue, 
the most important factor in permitting a 
good scintigram, remains very favorable for 
a considerable period of time. 
Thus the use of ITB offers the possibility 
of myocardial scintigrams that do not suf- 
fer from either of the two disadvantages 
of cesium-1311, weak emission and long 
biologic half-life. Cesium-131 has already 
been shown to be effective in man in dem- 
onstrating myocardial infarcts and other 
myocardial lesions; the possibility of ob- 
taining myocardial scintigrams with the 
more advanta.geous radioactive compound 
may significantly improve diagnosis of 
myocardial infarction in the future and may 
make it possible to evaluate more pre- 
cisely therapeutic regimens in myocardial 
infarction. It is of interest that the mean 
uptake of infarcted myocardium is about 
15 per cent the uptake by normal myo- 
cardium, whether one uses labeled toluidine 
blue or radioactive cesium. 
To our knowledge, the closest previous 
approach to demonstration of myocardial 
infarcts using a compound labeled with 
radioactive iodine was that reported by 
Gunton and associates,24 who reported 
that oleic acid labeled with iodine-131 
could be complexed to human serum albu- 
min and utilized in a technique which, 
according to the authors’ report, just ap- 
proached the limits of definition of infarc- 
tion when used for scintigrams in acute 
cases. As noted above, iodine-131 is likely 
to be a very satisfactory label for ITB. 
We have not thus far attempted to use 
iodine-123. However, despite the short 
physical half-life of iodine-123, its emission 
has a particularly favorable energy (159 
KEV) for use with a radiation camera. 
Therefore, the eventual possibility of using 
iodine-123 should not be entirely dis- 
counted, especially if one wishes to use a 
radiation camera rather than a scanner. 
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Table III. Radioactivity in hearts of dogs with myocardial infarcts* 
Dog 
l:ptaket by I LTptake by Radioactivity in 
normal L1’ normal LV _~~ 
Normal LV Infarcted LV ~ 
Uptake by radioactivity 
tissue tissue 
infarcted L V in blood 
I 
‘Q 0.88 0.11 0.13 13.62 
Elf 0.30 .98 0.015 .10 0.10 05 13.07 0 24
D 0.28 0.31 1.11 9.83 
E 1.48 0.07 0.05 9.16 
F 1.22 0.22 0.18 19.61 
G 0.87 0.14 0.16 9.31 
H 0.93 0.075 0.08 7.15 
f 0 1.36 51 0.06 06 0.04 1 18.92 80
Ii 0.29 0.02 0.07 8.29 
Mean * SD. 0.83 * 0.43 0.10 * 0.091 0.18 * 0.31 11.64 * 4.23 
*Each dog received 10 mg. per kilogram of body weight stable toluidine blue over 45 minutes preceding the bolus dose of radio-iodinated 
toluidine blue. Each dog was killed 15 minutes after the latter dose. See text for further details. 
tPer cent administered dose/Gm. 
$Differs significantly (p < 0.005) from normal left ventricular tissue. 
BNot the same dogs as dogs A, B, and C of Fig. 2. 
The mechanism whereby a priming dose 
of TB, first suggested by one of the authors 
(W. DiG.), influences the distribution of 
ITB is at present unknown. Both the rate 
of administration and the total dose of 
stable TB are significant, as suggested by 
the studies in rats. The use of a priming 
dose of TB does not increase the concen- 
tration of radionuclide in important non- 
target tissues (liver and blood). Indeed, the 
data in rats suggest lower radioactivity in 
these non-target tissues as a result of a 
priming dose of TB. It should be noted that 
the use of a priming dose does not increase 
the uptake of radionuclide by various other 
non-cardiac tissues after administration of 
ITB (e.g., muscle, lung, etc.) but data on 
liver and blood have been presented here, 
as they represent particularly important 
non-target tissues in the myocardial scinti- 
gram. 
One may postulate two types of binding 
site for the phenazathionium nucleus, such 
that one of the sites has a lower capacity 
but higher affinity than the other. Satura- 
tion of the first site-e.g., in liver and blood 
-by a priming dose of TB might then make 
more ITB available for the second site, in 
the myocardium. Such a mechanism is at 
present entirely speculative although the 
reported electrocardiographic changes after 
an intravenous injection of TB (see below) 
may be pertinent here. 
Toluidine blue has been used intra- 
venously in man14~15J5J6 in the past and has 
not proved to be a highly toxic compound. 
Kiese and associates25 gave 4 mg. per kilo- 
gram of body weight of TB intravenously 
to humans without ill effect. Doses of 6 mg. 
per kilogram of body weight have been 
given safely to humans intravenouslyz6; 
these doses w-ere given over a period of 
2 hours. Nevertheless, rapid infusion of a 
sufficiently high dose may result in electro- 
cardiographic changes. Whereas eight pa- 
tients studied by DiGiulio and Lindenaueri5 
received 5 mg. per kilogram of body weight 
of TB intravenously over periods ranging 
from 45 to 135 minutes without reported 
electrocardiographic abnormalities, one pa- 
tient who received 3.5 mg. per kilogram of 
body weight in 30 minutes did show tran- 
sient depression of the S-T segment. 
The development of cardiac arrhythmias 
after diagnostic procedures is by no means 
unknown, and even the barium enema is 
not innocuous in this regard,27 but particu- 
lar caution is clearly needed to avoid pre- 
cipitating cardiac arrhythmias in patients 
already suffering from myocardial infarcts. 
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Therefore, these data are recorded only to 
suggest that the requirement of a priming 
dose of stable toluidine blue need not pose 
an insuperable barrier to the use of ITB 
as a myocardial scanning agent. Although 
the animal studies reported here are prom- 
ising, the authors do not, of course, advo- 
cate that any initial trial in humans utilize 
10 mg. per kilogram of body weight as a 
starting dose, regardless of the rate of 
infusion. The same general rules that govern 
early human trials of therapeutic com- 
pounds must govern trials of diagnostic 
agents--the initial approach must be 
cautious, utilizing low doses. bIoreover, 
studies in normal subjects should precede 
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